Peer-reviewed veterinary case report
Safety of anti-Fel d 1 IgY ingredient in cat food tested
By Matulka, Ray A et al.·Published in Frontiers in veterinary science·2019·Burdock Group Consultants, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Multi-Level Safety Studies of Anti Fel d 1 IgY Ingredient in Cat Food.
- Species:
- cat
Plain-English summary
A group of cats was fed a special chicken egg product containing antibodies designed to reduce allergic reactions to cat allergens (Fel d 1) for six months. The study found that the cats tolerated the food well, with no noticeable side effects or health issues, and there were no signs of genetic damage from the ingredient. This suggests that the egg product is safe for cats and could potentially help reduce allergic reactions in people sensitive to cat allergens.
People also search for: cat food for allergies · safe cat food ingredients · reducing cat allergens in home
Abstract
Chickens exposed to antigens produce IgY antibodies, similar in structure to mammalian IgG. Hens exposed with an allergen produced by cats (Fel d 1) results in production of anti-Fel d 1 specific IgY (AFD1), which is naturally concentrated in egg yolk. A chicken egg product ingredient containing AFD1 was evaluated for safety in a 26-week randomized, controlled, blinded tolerance study in cats andfor mutagenic and genotoxic effects. Thestudy was conducted with groups fed kibble containing 0, 7, 39, or 66 ppm AFD1. Parameters examined included: clinical observations, body weights, food consumption, serum chemistry, hematology, blood coagulation, urinalyses, and mortality and morbidity checks. AFD1 was evaluated for potential mutagenic effects utilizing the bacterial reverse mutation assay at concentrations of up to 2.78 ppm and for potential structural chromosomal aberrations at up to 3 ppm using human peripheral blood lymphocytes (HPBL). After 6-months of feeding to cats, there were no significant differences between control and any test groups in any parameters analyzed. No significant increases in mutations or chromosomal aberrations were observed in tests with or without metabolic activation (S9). These studies show AFD1 was well-tolerated in cats at levels tested and does not induce mutagenic or chromosomal aberrations under study conditions.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/31970163/